(Q52064896)

21 April 2018

title

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment. (English)

1 reference

21 April 2018

author name string

Johannessen JN

1

1 reference

21 April 2018

Chiueh CC

2

1 reference

21 April 2018

Bacon JP

3

1 reference

21 April 2018

Garrick NA

4

1 reference

21 April 2018

Burns RS

5

1 reference

21 April 2018

Weise VK

6

1 reference

21 April 2018

Kopin IJ

7

1 reference

21 April 2018

Parisi JE

8

1 reference

21 April 2018

Markey SP

9

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 August 1989

1 reference

21 April 2018

Journal of Neurochemistry

published in

1 reference

21 April 2018

volume

53

1 reference

21 April 2018

issue

2

1 reference

21 April 2018

page(s)

582-589

1 reference

21 April 2018

The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

A simple and sensitive assay for dopamine-beta-hydroxylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Modification of the tyrosine hydroxylase assay. Increased enzyme activity in the presence of ascorbic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

In vivo effect of MPTP on monoamine oxidase activity in mouse striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Quantification of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion in brain tissue by gas chromatography/mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

Assay of tyrosine hydroxylase by coupled decarboxylation of DOPA formed from 1- 14 C-L-tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

A Parkinson-like neurologic deficit in primates is caused by a novel 4-substituted piperidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB07373.X

10.1111/J.1471-4159.1989.TB07373.X

21 January 2018

Identifiers

DOI

1 reference

21 April 2018

PubMed ID

2568405

1 reference

21 April 2018